Nov 07, 2025 This Week in Cardiology
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
Listener feedback on non-culprit PCI in STEMI, a major cardiac result in patients on hemodialysis, news on GLP-1 agonists, a dubious stroke trial, and an AHA preview are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I Listener Feedback
- Meta-analysis of MI as a surrogate https://pubmed.ncbi.nlm.nih.gov/34694318/
- Compare Acute Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1701067
- DANAMI-3–PRIMULTI 10.1016/S0140-6736(15)60648-1 External Link
- CULPRIT-SHOCK https://www.nejm.org/doi/full/10.1056/NEJMoa1710261
II Huge Cardiac News for Patients with ESRD PISCES article EMBARGOED Till 1130 AM EST
- PISCES Trial www.nejm.org/doi/full/10.1056/NEJMoa2513032
- REDUCE-IT Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1812792
- STRENGTH Trial https://jamanetwork.com/journals/jama/fullarticle/2773120
- FISH trial https://jamanetwork.com/journals/jama/fullarticle/1150094
III Obesity Agents
- White House announces deal with Lilly and Novo on GLP-1 drugs https://www.reuters.com/business/healthcare-pharmaceuticals/novo-lilly-shares-rise-trump-obesity-drug-deal-nears-2025-11-06/
Amylin Agonists
- Amylin Analog Eloralintide Reduces Weight in Phase 2 Trial
https://www.medscape.com/viewarticle/amylin-analog-eloralintide-reduces-weight-phase-2-trial-2025a1000uqf
- Eloralintide Phase 2 Study https://doi.org/10.1016/S0140-6736(25)02155-5
GLP-1 Comparisons
- SURMOUNT-5 Trial https://www.nejm.org/doi/10.1056/NEJMoa2416394
- Tirzepatide vs Semaglutide in 10-year CVD Risk Reduction https://doi.org/10.1093/ehjopen/oeaf117
IV A Problematic Trial in Stroke Care
- LAMP trial https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2840370
V AHA Preview
AHA 2025: Mandrola's Four Trials to Look For https://www.medscape.com/viewarticle/aha-2025-mandrolas-four-trials-look-2025a1000u80
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net